دسترسی یکساله به بیش از ۵۰۰ ژورنال روز جهان موجود در سامانه
-
http://medilib.ir
- ﻣﺪﺕ ﺯﻣﺎﻥ : 365 ﺭﻭﺯ
قیمت : 3,800,000 تومان- قیمت ویژه : 1,900,000تومان
Polio eradication: falling at the final hurdle?
doi : 10.1016/S0140-6736(22)01875-X
Volume 400, Issue 10358, 1–7 October 2022, Page 1079
Identifying patients for adjuvant therapy after nephrectomy
UmbertoCapitanioabFrancescoMontorsiab
Adjuvant checkpoint blockade following complete local therapy for melanoma metastases
James WSmithyaMichael APostowa
Coloniality and racism impacts the health of young people
Paula TokoKingaBridgetRobsona
Power and the planetary health equity crisis
SharonFrielaMeganArthuraNicholasFranka
The UK COVID-19 Inquiry must examine the foundations of pandemic decision making
TomLawtonaNisreen AAlwanb
Global Fund secures $14·3 billion from donors
Miriam LewisSabin
Rhea Boyd: paediatrician advocating for health equity
AarathiPrasad
Biopower, racism, and yellow feverKathryn Olivarius, Necropolis: Disease, Power, and Capitalism in the Cotton Kingdom, Belknap Press of Harvard University Press (2022), p. 352, US$35·00, £28·95, ISBN: 9780674241053
Richard MMizelleJr
A healthy future for children and adolescents
AnitaKaraAmrutaChutkebCharutaGokhalecSupriyaPhadnisdBhagyashreeRadhakrishnana
A healthy future for children and adolescents
Anthony ALavertyaChristopherMillettaJasper VBeenbFilippos TFilippidisaMárta KRadóc
A healthy future for children and adolescents
NinaRenshawaRosamundAdoo-Kissi-DebrahbArvindKumarcdLabram MassawuduMusaheJaneBursona
A healthy future for children and adolescents
Robert CHughesaMartinAntoniodRhiannonOsborneeSusannah HMayhewbAndyHainesc
A healthy future for children and adolescents – Authors' reply
Zulfiqar ABhuttaabTylerVaivadaaMaureen MBlackcdRobert EBlacke
Adjuvant atezolizumab versus placebo for patients with renal cell carcinoma at increased risk of recurrence following resection (IMmotion010): a multicentre, randomised, double-blind, phase 3 trial
ProfSumanta KumarPalMDa†ProfRobertUzzoMDb†Jose AntonioKaramMDdeProfViraj AMasterMDfProfFredeDonskovMDghCristinaSuarezMDiLaurenceAlbigesMDjProfBrianRiniMDkProfYoshihikoTomitaMDlAriel GalapoKannMDmGiuseppeProcopioMDnFrancescoMassariMDoMatthewZibelmanMDcIgorAntonyanMCpMahrukhHuseniMSqDebasmitaBasuMSrBoCiPhDqWilliamLeungPharmDq…ProfAxelBexMDst
Adjuvant nivolumab plus ipilimumab or nivolumab alone versus placebo in patients with resected stage IV melanoma with no evidence of disease (IMMUNED): final results of a randomised, double-blind, phase 2 trial
ElisabethLivingstoneMDa†LisaZimmerMDa†ProfJessica CHasselMDbMichaelFluckMDcProfThomas KEigentlerMDdeProfCarmenLoquaiMDfSebastianHaferkampMDgProfRalfGutzmerMDhiProfFriedegundMeierMDjPeterMohrMDkProfAxelHauschildMDlProfBastianSchillingMDmChristianMenzerMDbFelixKieckerMDenProfEdgarDippelMDoProfAlexanderRoeschMDatMirjanaZiemerMDpBeateConradMDc…DirkSchadendorf
Flexible resources and experiences of racism among a multi-ethnic adolescent population in Aotearoa, New Zealand: an intersectional analysis of health and socioeconomic inequities using survey data
RachelSimon-KumarPhDa†SoniaLewyckaPhDc†ProfTerryann CClarkPhDbTheresaFlemingPhDdRoshiniPeiris-JohnPhDa
Fragile X-associated tremor or ataxia syndrome in a patient with difficulty walking, falls, a tremor, and erectile dysfunction
Daniel Sabinode OliveiraMScaAndré IglesiasBrandãoMDaThiago CardosoValePhDab
Acute respiratory distress syndrome: causes, pathophysiology, and phenotypes
Lieuwe D JBosPhDaProfLorraine BWareMDb
Acute respiratory distress syndrome in adults: diagnosis, outcomes, long-term sequelae, and management
Ellen AGormanMB BCh BAOaProfCecilia MO’KanePhDaProfDaniel FMcAuleyMDa
